Explore 3 Stock Ideas & Industry Insights Download Free Report

Big Pharma Split Corp

Company price
None CAD 0.00(0%)
Last update at 2026-11-04T17:03:45.425558Z
Market Cap
0.00M
P/E
2.97

Momentum Score

…

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
8.71
Low
10.38
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
10.22
Dividend Yield
5.25%
Revenue TTM
2.65M
Revenue Per Share
1.92
Gross Profit TTM
5.56M
Debt / Equity
-
ROE
-1.14%
Net Debt
-
ROCE
20.56%
Diluted EPS TTM
3.27

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3.15M 4.85M 0.27M 3.14M 2.78M
Net income 3.15M 4.85M 0.27M 3.14M 2.78M
Selling general administrative 0.36M 0.37M 0.22M 0.29M 0.32M
Gross profit - - - 2.20M 6.40M
Ebit - 4.61M 0.19M 1.76M 5.66M
Ebitda - - - 1.80M 5.95M
Operating income - - - 1.80M 5.95M
Other operating expenses - 0.12M 0.10M 0.11M 0.12M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Total revenue 3.71M 5.36M 0.59M 2.43M 3.23M
Total operating expenses - - - 0.63M 0.73M
Cost of revenue - - - 0.24M 0.27M
Total other income expense net - - - 1.34M -3.17M
Net income from continuing ops 3.15M 4.85M 0.27M 3.14M 2.78M
Net income applicable to common shares - 4.21M -0.22M 2.58M 2.10M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 39.10M 37.81M 22.93M 27.18M 33.63M
Other current assets - 0.81M 0.04M 0.24M -
Total liab 19.37M 15.41M 9.75M 10.87M 14.79M
Total stockholder equity 19.73M 22.40M 13.19M 16.31M 18.84M
Other current liab - 0.55M 0.40M 0.29M 1.38M
Common stock - 22.40M 13.19M 16.31M 18.84M
Cash 0.82M 1.43M 0.23M 0.54M 0.42M
Total current liabilities - 15.41M 9.75M 10.87M 14.79M
Total current assets - 2.50M 0.53M 0.84M 0.49M
Long term investments 24.27M 36.13M 22.45M - 33.14M
Net tangible assets - 22.40M 13.19M 16.31M 18.84M
Short term investments - - - 26.33M 33.14M
Net receivables - 0.25M 0.26M 0.07M 0.07M
Accounts payable 0.35M 0.34M 0.21M - 0.31M
Non current assets total - - - 0.00M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Change to liabilities - 0.00M 0.00M 0.00M 0.00M
Total cash from financing activities - 10.19M -4.65M -8.57M -2.71M
Change to operating activities - -0.15M -0.03M -0.00M -0.05M
Net income 3.15M 4.21M -0.22M 2.58M 2.10M
Change in cash -0.61M 1.20M -0.31M 0.12M -1.43M
Begin period cash flow 1.43M 0.23M 0.54M 0.42M 1.85M
End period cash flow 0.82M 1.43M 0.23M 0.54M 0.42M
Total cash from operating activities 1.13M -9.00M 4.35M 8.68M 1.27M
Issuance of capital stock 0.88M 13.32M - - 0.00M
Dividends paid 2.62M 2.84M 1.73M 2.08M 2.25M
Sale purchase of stock - - -2.92M -6.49M -0.46M
Other cashflows from financing activities - -0.29M -0.29M -0.29M -0.29M
Change to netincome - -13.06M 4.60M 6.10M -0.78M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.18M -0.15M -0.03M -0.00M -0.05M
Other non cash items -0.00M -0.23M - 8.35M 2.38M
Free cash flow 1.13M -9.00M 4.35M 8.68M 1.27M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
BLK
BlackRock CDR (CAD Hedged)
1.66
5.64%
31.10 25.23 18.90 6.38 2.79
BN
Brookfield Corporation
2.94
5.16%
59.78 94.76 11.96 1.84 2.36
BAM
Brookfield Asset Management Ltd
4.11
5.76%
75.43 31.22 25.51 22.40 9.70
PHYS
Sprott Physical Gold Trust
1.05
2.52%
42.64 3.81 - 3.47 1.06

Profile*

Big Pharma Split Corp

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

416-649-4541

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…